Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Matthijs Oudkerk, MD, PhD, University of Groningen, Groningen, Netherlands, provides an overview of the impact of the COVID-19 pandemic on lung cancer screening programmes, touching on consequences in the academic research setting and clinical trial develoment. This interview took place during the virtual European Lung Cancer Congress 2022.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.